Skip navigation

HHS and DoD partner with Johnson & Johnson to produce COVID-19 investigational vaccine doses

The U.S. Department of Health and Human Services and Department of Defense announced an agreement with Johnson & Johnson, to demonstrate large-scale manufacturing and delivery of the company's COVID-19 vaccine candidate for use in clinical trials, or to vaccinate individuals if authorized by the Food and Drug Administration. This partnership builds toward the U.S. government's Operation Warp Speed goal to begin delivering millions of doses of safe and effective vaccines by the end of the year.